UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
LABARGE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
5024709C
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2006
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
----------
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 5024709C 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Sanfurd G. Bluestein, M.D.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
894,000(1)
-----------------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 663,300(1)
OWNED BY -----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON 894,000(1)
WITH -----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
663,300(1)
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,577,300(1)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
10.21%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
(1) The shares of Common Stock include (A) 757,000 shares (representing 4.96% of
the class) owned directly by Sanfurd G. Bluestein, M.D. ("Bluestein"), over
which Bluestein has sole voting and investment control, (B) 137,000 shares
(representing 0.90% of the class) held by Oppenheimer & Co. Inc. custodian for
Sanfurd G. Bluestein IRA, over which Bluestein has sole voting and investment
control, and (C) shares held in the accounts of the persons named below, over
which Bluestein shares voting and investment control pursuant to third party
trading authorizations:
1. Bluestein Family Partnership, LP, a limited partnership organized under
the laws of the state of New Jersey, which held 175,000 shares of Common
Stock (representing 1.15% of the class) as of December 31, 2006 (the
"Disclosure Date").
2. Bluestein Family Foundation Inc., a private foundation of which Bluestein
is the Manager, which held 187,500 shares of Common Stock (representing
1.23% of the class) as of the Disclosure Date.
3. Joel Bluestein, Bluestein's son, who held 175,000 shares of Common Stock
(representing 1.15% of the class) as of the Disclosure Date.
4. Doris Hasnas, Bluestein's sister, who held 10,800 shares of Common Stock
(representing 0.07% of the class) as of the Disclosure Date.
5. Jessica Ann Bishop Trust #2, Joel Bluestein Trustee, U/A/D 11/23/1998
F/B/O Jessica Bishop, a trust for the benefit of Bluestein's
granddaughter, which held 55,000 shares of Common Stock (representing
0.36% of the class) as of the Disclosure Date.
6. Jessica Reisman Trust #2, Abbey Ann Reisman Trustee U/A/D 11/23/1998 F/B/O
Jessica Reisman, a trust for the benefit of Bluestein's granddaughter,
which held 60,000 shares of Common Stock (representing 0.39% of the class)
as of the Disclosure Date.
Item 1 (a) Name of Issuer: LaBarge, Inc.
--------------------------------------------------------------------
Item 1 (b) Address of Issuer's Principal Executive Offices:
9900A Clayton Road, St. Louis, MO 63124
--------------------------------------------------------------------
Item 2 (a) Name of Person Filing: Sanfurd G. Bluestein, M.D. ("Bluestein").
--------------------------------------------------------------------
Item 2 (b) Address of Principal Business Office or, if none, Residence:
309 Upper Mountain Avenue, Upper Montclair, NJ 07043-1015
--------------------------------------------------------------------
Item 2 (c) Citizenship: Bluestein is a United States citizen.
--------------------------------------------------------------------
Item 2 (d) Title of Class of Securities: Common Stock, par value $0.01 per
share ("Common Stock")
--------------------------------------------------------------------
Item 2 (e) CUSIP Number: 5024709C
--------------------------------------------------------------------
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or
(c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Exchange
Act;
(b) [ ] Bank as defined in section 3(a)(6) of the Exchange Act;
(c) [ ] Insurance company as defined in section 3(a)(19) of the Exchange
Act;
(d) [ ] Investment company registered under Section 8 of the Investment
Company Act;
(e) [ ] An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [ ] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership.
Amount beneficially owned:
(a) Bluestein is the beneficial owner of 1,557,300 shares of Common
Stock(1).
(b) Percent of class: 10.21%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 894,000(1)
(ii) Shared power to vote or to direct the vote: 663,300(1)
(iii) Sole power to dispose or to direct the disposition of:
894,000(1)
(iv) Shared power to dispose or to direct the disposition of:
663,300(1)
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company or
Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of the knowledge and belief of
the undersigned, the undersigned certifies that the information set forth in
this statement is true, complete and correct.
/s/Sanfurd G. Bluestein, M.D.
-------------------------------
Sanfurd G. Bluestein, M.D.
Dated: January 16, 2007
Upper Montclair, New Jersey